• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP Back to Search Results
Catalog Number PAH131002E
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/02/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Results code: a review of the manufacturing records for the device verified the lot met all pre-release specifications.An engineering evaluation is currently in progress.
 
Event Description
On (b)(6) 2017, a patient was being treated for a left common iliac artery aneurysm with two gore® viabahn® endoprostheses with heparin bioactive surface.An aorfix endoprosthesis was utilized as a main body aortic component.The first viabahn was placed in the left common iliac artery and covered the left hypogastric artery.The second viabahn was used as a bridge between the aorfix and the first viabahn.The second viabahn was advanced through a 12fr cook high flex introducer sheath from the left brachial artery.Once the device was in the target location, the introducer sheath was pulled back until almost all of the endoprosthesis was exposed.The deployment was initiated slowly, without incident.Before the deployment reached the introducer sheath, deployment was stopped in order to pull the sheath back more.The deployment line was then pulled again, but it felt as if there was bowstringing, and the deployment line would not release.After pulling hard, the deployment line did release from the catheter, but the catheter could not be withdrawn.Some maneuvering was performed and eventually the entire catheter was removed.Since the proximal part of the viabahn remained constrained, the procedure was completed by placing a balloon expandable covered stent to secure the overlap between the aorfix endoprosthesis and the viabahn bridging component.It is not known whether any deployment line fragments remain in the patient, however the patient did well following the procedure.
 
Manufacturer Narrative
The delivery catheter, the deployment knob and the deployment line were received with no endoprosthesis returned.The engineering evaluation stated that approximately 172 cm of the deployment line was connected to deployment knob, with a fiber extending 8 cm further.The end deployment line fibers appeared broken and frayed.Based on the engineering evaluation performed, no manufacturing anomalies were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
nataliya baramzina
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6986138
MDR Text Key91221610
Report Number2017233-2017-00566
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/02/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2020
Device Catalogue NumberPAH131002E
Device Lot Number16597048
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/13/2017
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/28/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received11/14/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/01/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age84 YR
-
-